This brief summarizes the contributions of Kaiser Permanente Research on the topic of diabetes since 2007, including type 1, type 2, and gestational diabetes.
The Centers for Disease Control and Prevention estimates that 30.3 million people in the United States — more than 9% of the population — are living with diabetes, and an additional 34% of U.S. adults have prediabetes.1
The prevalence of both diabetes (25%) and prediabetes (48%) is higher among adults age 65 or older than among those under age 65.
Diabetes is an active area of study for Kaiser Permanente Research. Scientists across the organization have used our rich, comprehensive, longitudinal data to advance understanding of risk, improving patient outcomes, and translating research findings into policy and practice. We have published more than 1,100 articles related to diabetes since 2007; together, they have been cited approximately 55,000 times.2
These articles are the product of observational studies, randomized controlled trials, meta-analyses, and other studies led by Kaiser Permanente scientists. The unique environment — which includes our fully integrated care and coverage model — in which our research scientists, clinicians, medical groups, and health plan leaders collaborate enables us to contribute generalizable knowledge on diabetes and many other topics of research.